GNT Biotech & Medicals Corporation announced earnings results for the half year ended June 30, 2021. For the half year, the company announced sales was TWD 300,000. Operating loss was TWD 17.450 million compared to TWD 13.323 million a year ago. Net loss was TWD 17.422 million compared to TWD 12.329 million a year ago. Basic loss per share from continuing operations was TWD 0.89 compared to TWD 0.86 a year ago.